Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apervita was a Chicago-based healthcare technology company that specialized in clinical intelligence and value-based care platforms. The company's primary offering was a cloud-based ecosystem that allowed healthcare providers and payers to collaborate using standardized clinical algorithms and quality measures. By automating the processing of electronic clinical quality measures (eCQMs), Apervita aimed to improve patient outcomes and streamline financial performance in value-based contracts. Despite significant venture backing and partnerships with organizations like the Joint Commission, the company ceased independent operations in late 2021. Its quality measurement assets were subsequently acquired by Q-Centrix in early 2022.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apervita.